Does oatmeal lower cholesterol?

Yes, by a small amount. In 17 randomized trials with 1731 people who had high cholesterol, oat products eaten for at least 4 weeks lowered LDL cholesterol by 9.3 mg/dL (95% CI 5.8 to 13; metric: 0.24 mmol/L, 0.15 to 0.33), on moderate certainty evidence. A larger pooling of 58 trials found a drop of 0.19 mmol/L. Nobody has shown yet that this prevents heart attacks.

Established. Oats lower LDL cholesterol. Three meta-analyses of oat trials land between 0.19 and 0.25 mmol/L, and a fourth on beta-glucan from oats and other sources found 0.26 mmol/L. An umbrella review of 108 systematic reviews and 37 guidelines rated foods high in soluble fiber, oats among them, as causing at least moderate LDL reductions of 7.7 to 15 mg/dL (0.20 to 0.40 mmol/L) on high quality evidence. That range covers oats, barley and psyllium together.

What the trials found

The most direct answer comes from a 2024 meta-analysis of 17 trials in people with dyslipidemia, who ate oat beta-glucan, oat bran or wholegrain oat products for 4 weeks or longer. LDL fell by 9.3 mg/dL (0.24 mmol/L) and total cholesterol by 12 mg/dL (6.6 to 19; metric: 0.32 mmol/L, 0.17 to 0.48). Against other cereals the LDL gap was 6.6 mg/dL (0.17 mmol/L). HDL and triglycerides barely moved. Most of those trials were at high risk of bias or raised some concerns, which is why the certainty is moderate.

The other pooled analyses measure the active fiber, oat beta-glucan. Across 28 trials, 3 g or more a day lowered LDL by 9.7 mg/dL (0.25 mmol/L), with a larger effect in people whose LDL started higher. Part of that analysis rests on in-house reports of an industry consultancy. It found no extra benefit between 3.0 and 12.4 g a day. A 58-trial analysis with 3974 people found a median 3.5 g a day lowered LDL by 7.3 mg/dL (5.4 to 8.9; metric: 0.19 mmol/L, 0.14 to 0.23), with large unexplained differences between trials (I2 79 percent).

Whole oats and isolated oat beta-glucan both worked in a 2023 analysis of 28 blinded trials with 1494 adults. That review reports only standardized effects, so its size cannot be put in mmol/L.

Unsettled. Real oatmeal, eaten as a meal, has less trial evidence than oat fiber. In a 6-week double-blind feeding trial on 68 adults, four servings of whole grain oats per 2000 calories lowered LDL by 11.2 mg/dL against a control diet with 0.8 servings. The difference across diets did not reach significance (p 0.064). We have no card on how much beta-glucan an ordinary bowl carries, or on how much of the effect survives in instant oats.

Who should be careful

In the 17 trials in people with high cholesterol, side effects were mostly mild gut symptoms. Diarrhea, nausea and wind were the most common. The review described them without pooling a rate.

Not for everyone. People with celiac disease need pure, uncontaminated oats. In pooled trial and observational data, with 661 patients in the trials, pure oats in a gluten-free diet for 12 months did not worsen symptoms or gut histology, on low quality evidence from few studies. Ordinary oats are a different matter. Across 40 food-testing studies, 15 percent of gluten-free foods carried more than 20 mg/kg of gluten, and oats were the most contaminated food. That is laboratory testing of food, and the abstract gives no rate for oats alone.

We found no card on oats and medicines, pregnancy or children for this question.

What expert bodies say

Regulators on both sides of the Atlantic accept the claim. The FDA allows a heart health claim for soluble fiber only in diets supplying 3 g or more of beta-glucan a day from whole oats or barley. The EU authorizes the claim that oat beta-glucan lowers blood cholesterol. Its condition of use, 3 g of beta-glucan a day, sits in Regulation 1160/2011 rather than in the register entry we read. These are regulatory decisions, and they match the trial evidence above rather than adding to it.

How we searched

What would change this answer

• A trial of oats on heart attacks, strokes or deaths. We found none. One trial inside the 2024 review found no difference in major cardiovascular events. For now the effect is on LDL and non-HDL cholesterol only.
• Trials of ordinary porridge and instant oats at the portions people eat, reported in mmol/L. Most of the evidence tests a dose of beta-glucan rather than a bowl.
• We did not search the trial registry separately for oat trials, so running trials may exist that this page does not know about.

Nutrition values, other findings and practical notes for the food itself are on the oatmeal and rolled oats page.

Sources

1. ev-oatchol-01 · Meta-analysis or systematic review · systematic review and meta-analysis of randomized trials · n = 1731
   Pooled estimates showed that oat-based products may result in a large reduction in LDL-C (WMD, -0.24 mmol L-1; 95% CI: -0.33, -0.15) (moderate certainty) and TC (WMD, -0.32 mmol L-1; 95% CI: -0.48, -0.17) (moderate certainty).
   
   Who: patients with dyslipidemia, oat beta-glucan, oat bran or wholegrain oat products for 4 weeks or more vs placebo or usual diet
   Effect: LDL-C WMD -9.3 mg/dL (95% CI -13 to -5.8; metric: -0.24 mmol/L, -0.33 to -0.15); total cholesterol -12 mg/dL (-19 to -6.6; metric: -0.32 mmol/L, -0.48 to -0.17); vs other cereals LDL-C -6.6 mg/dL (-0.17 mmol/L); little effect on HDL-C and triglycerides
   Certainty: Moderate certainty by GRADE; most trials at high risk of bias or some concerns; one trial found no difference in major cardiovascular events.
   Food Funct, 2024 · checked 2026-10-06 · we read the abstract
2. ev-oatchol-02 · Meta-analysis or systematic review · meta-analysis of randomized trials · n = —
   OBG in doses of ≥3 g/d reduced low-density lipoprotein (LDL) and total cholesterol relative to control by 0.25 mmol/L (95% CI: 0.20, 0.30; P < 0.0001) and 0.30 mmol/L (95% CI: 0.24, 0.35; P < 0.0001), respectively
   
   Who: adults in randomized trials of 3 g/day or more of oat beta-glucan vs control, 2 to 12 weeks
   Effect: LDL -9.7 mg/dL (95% CI 7.7 to 12; metric: -0.25 mmol/L, 0.20 to 0.30); total cholesterol -12 mg/dL (9.3 to 14; metric: -0.30 mmol/L, 0.24 to 0.35); no change in HDL or triglycerides; larger effect with higher baseline LDL
   Certainty: Partly based on in-house reports of an industry consultancy; no dose-response seen between 3.0 and 12.4 g/day.
   Am J Clin Nutr, 2014 · checked 2026-10-06 · we read the abstract
3. ev-oatchol-03 · Meta-analysis or systematic review · systematic review and meta-analysis of randomized trials · n = 3974
   A median dose of 3·5 g/d of oat β-glucan significantly lowered LDL-cholesterol (-0·19; 95 % CI -0·23, -0·14 mmol/l, P<0·00001)
   
   Who: adults in randomized trials of at least 3 weeks, diets enriched with oat beta-glucan vs control diets
   Effect: LDL -7.3 mg/dL (95% CI -8.9 to -5.4; metric: -0.19 mmol/L, -0.23 to -0.14); non-HDL -7.7 mg/dL (-10 to -5.8; metric: -0.20 mmol/L, -0.26 to -0.15); apoB -0.03 g/L (-0.05 to -0.02)
   Certainty: Considerable unexplained heterogeneity (I2 79% for LDL); the abstract gives no percentage change.
   Br J Nutr, 2016 · checked 2026-10-06 · we read the abstract
4. ev-oatchol-04 · Meta-analysis or systematic review · meta-analysis of randomized trials · n = 1120
   consuming a dose of ≥3 g/d of β-glucan for at least 3 weeks could significantly reduce total cholesterol (TC) (-0·27 mmol/l, 95 % CI -0·33, -0·21, P < 0·001) and LDL-cholesterol (-0·26 mmol/l, 95% CI -0·32, -0·20, P < 0·001)
   
   Who: mildly hypercholesterolemic adults, beta-glucan 3 g/day or more for at least 3 weeks, various food matrices
   Effect: LDL -10 mg/dL (95% CI -12 to -7.7; metric: -0.26 mmol/L, -0.32 to -0.20); total cholesterol -10 mg/dL (-13 to -8.1; metric: -0.27 mmol/L, -0.33 to -0.21); no change in triglycerides or HDL
   Certainty: Beta-glucan from oats and other sources pooled; modest heterogeneity.
   Br J Nutr, 2021 · checked 2026-10-06 · we read the abstract
5. ev-oatchol-05 · Meta-analysis or systematic review · systematic review and meta-analysis of randomized trials · n = 1494
   isolated β-glucan interventions from parallel-arm studies decreased TC (-0.73, 95%CI: -1.01;-0.45, p < 0.00001), LDL (-0.58, 95%CI: -0.85;-0.32, p < 0.0001) and triglycerides (-0.30, 95%CI: -0.49;-0.12, p = 0.001).
   
   Who: adults 18 and over with or without high cholesterol, blinded randomized trials of oats or isolated beta-glucan for at least 2 weeks
   Effect: isolated beta-glucan parallel trials: total cholesterol SMD -0.73 (95% CI -1.01 to -0.45), LDL SMD -0.58 (-0.85 to -0.32), triglycerides SMD -0.30
   Certainty: Results given as standardized mean differences, not mmol/L, so size in everyday units is not stated.
   Clin Nutr ESPEN, 2023 · checked 2026-10-06 · we read the abstract
6. ev-oatchol-06 · Meta-analysis or systematic review · systematic review of systematic reviews and guidelines · n = —
   With high evidence, foods high in unsaturated and low in saturated and trans fatty acids (e.g. rapeseed/canola oil), with added plant sterols/stanols, and high in soluble fiber (e.g. oats, barley, and psyllium) caused at least moderate (i.e. 0.20-0.40 mmol/L) reductions in LDL cholesterol.
   
   Who: adults, umbrella review of guidelines, systematic reviews and trials on foods and LDL cholesterol
   Effect: oats, barley and psyllium: LDL reduction 7.7-15 mg/dL (0.20-0.40 mmol/L), high GRADE evidence
   Certainty: Range is a category across foods, not an oat-specific pooled estimate.
   Nutr Metab Cardiovasc Dis, 2021 · checked 2026-10-06 · we read the abstract
7. ev-oatchol-07 · Randomized controlled trial(s) · double-blind parallel randomized controlled feeding trial · n = 68
   LDL cholesterol concentrations show a trend of statistical significance across diets (p = 0.0638), with a lowering of 8.9 mg/dL (barley) and 11.2 mg/dL (oats) compared to the control.
   
   Who: 68 adults, 6-week controlled feeding, 4 servings of whole grain oats per 2000 calories vs 0.8 servings in control
   Effect: LDL -11.2 mg/dL vs control (p for diet trend 0.064); oat diet lowered total and small LDL particles
   Certainty: Small trial; LDL difference across diets not significant at 0.05.
   Nutrients, 2026 · checked 2026-10-06 · we read the abstract
8. ev-oatchol-08 · Observational data · systematic review and meta-analysis of trials and observational studies · n = 661
   Oat consumption for 12 months did not affect symptoms (standardized mean difference: reduction in symptom scores in patients who did and did not consume oats, -0.22; 95% CI, -0.56 to 0.13; P = .22)
   
   Who: patients with celiac disease on a gluten-free diet, pure/uncontaminated oats, adults and children
   Effect: symptom score SMD -0.22 (95% CI -0.56 to 0.13); histology RR 0.24 (0.01-4.8); no change in serology
   Certainty: Low quality of evidence and few studies per endpoint; applies only to pure oats, not ordinary oats that may carry wheat or barley.
   Gastroenterology, 2017 · checked 2026-10-06 · we read the abstract
9. ev-oatchol-09 · Laboratory or animal data · meta-analysis of food contamination analyses · n = —
   Moreover, it was noticed that oats were the most contaminated food.
   
   Who: laboratory analyses of gluten-free foods, labeled and naturally gluten-free, 40 studies
   Effect: overall contamination above 20 mg/kg 15.12% (95% CI 9.56-21.70%); naturally gluten-free foods 28.32%; oats most contaminated
   Certainty: Food testing, not human outcomes; oat-specific rate not given in the abstract.
   Br J Nutr, 2022 · checked 2026-10-06 · we read the abstract
10. ev-oatchol-10 · Meta-analysis or systematic review · systematic review and meta-analysis of randomized trials · n = 1731
    Oat-related adverse events were mostly gastrointestinal such as diarrhea, nausea, and flatulence being the most prevalent.
    
    Who: patients with dyslipidemia in 17 randomized trials of oat-based products
    Effect: adverse events mainly gastrointestinal: diarrhea, nausea, flatulence; rates not pooled in the abstract
    Certainty: Adverse events described, not pooled into a risk ratio.
    Food Funct, 2024 · checked 2026-10-06 · we read the abstract
11. ev-oatchol-11 · Position of an expert body · federal regulation text · n = —
    ( 1 ) 3 g or more per day of β-glucan soluble fiber from either whole oats or barley, or a combination of whole oats and barley.
    
    Who: 21 CFR 101.81(c), soluble fiber from certain foods and coronary heart disease
    Effect: qualifying intake: 3 g/day or more of beta-glucan soluble fiber from whole oats or barley
    Certainty: Claim authorization is a regulatory decision, not a pooled estimate.
    21 CFR 101.81, Health claims: Soluble fiber from certain foods and risk of coronary heart disease (CHD) · checked 2026-10-06 · we read the section
12. ev-oatchol-12 · Position of an expert body · regulatory register entry · n = —
    POL-HC-6248 Oat beta-glucan Oat beta-glucan has been shown to lower/reduce blood cholesterol. High cholesterol is a risk factor in the development of coronary heart disease -/- Authorised
    
    Who: EU Register of nutrition and health claims, claim POL-HC-6248
    Effect: authorized
    Certainty: Condition of use (3 g beta-glucan a day) is in Regulation 1160/2011, not in the register snapshot.
    EU Register on nutrition and health claims, claim POL-HC-6248, snapshot 2026-09-21 · checked 2026-10-06 · we read the dataset